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Reporting recently inNature andNature Structural andMolecular Biology, Shen et al. (2013) and Smibert et al.
(2013) uncover mechanisms for Argonaute (Ago) protein regulation. Smibert et al. find that microRNA
availability controls Ago levels, and Shen et al. show that epidermal growth factor receptor-mediated
Ago2 phosphorylation affects Ago loading.Small RNAs such asmicroRNAs (miRNAs)
or short interfering RNAs (siRNAs) asso-
ciate with Ago proteins and regulate
cellular processes in many different spe-
cies. miRNAs are generated from
hairpin-structured precursors by the con-
secutive action of the two RNase III
enzymes Drosha and Dicer. Following
these cleavage steps, a single-stranded
mature miRNA is loaded onto an Ago pro-
tein and the RNA-induced silencing com-
plex (RISC) is formed. In animals, miRNAs
guide RISC to partially complementary
sequences typically located in the 30 un-
translated region (UTR) of target
messenger RNAs (mRNAs). As a con-
sequence, the mRNA is translationally
silenced and/or exonucleolytically de-
graded (Huntzinger and Izaurralde,
2011). siRNAs are generated from long
double-stranded RNAs, which can origi-
nate either from exogenous (synthetic
siRNAs, viral RNAs, etc.) or endogenous
(long hairpins, sense-antisense transcrip-
tion) sources. Similar to miRNAs, Dicer
processes these long RNA precursors
into siRNAs, which are then loaded onto
an Ago protein. Ago-associated siRNAs
often recognize fully complementary
target RNAs, and a catalytically active
Ago protein (e.g., Ago2 in mammals)
then cleaves the target RNA sequence-
specifically (Kim et al., 2009). Ago pro-
teins are at the heart of both small RNA
pathways, and therefore Ago protein
levels, as well as their functions, are highly
regulated. Two recent publications, Smi-
bert et al. (2013) in Nature Structural and
Molecular Biology and Shen et al. (2013)
in Nature, now provide insights into how
Ago protein levels and Ago loading pro-
cesses are controlled (Figure 1).To explore the regulation of Ago, Smi-
bert et al. (2013) used the Drosophila
system in which the miRNA and the
siRNA pathways are clearly distinct.
Compared to mammals, in which there
is only one Dicer and in which both
miRNAs and siRNAs can be loaded onto
all Ago proteins, Drosophila Dicer1
(Dcr1) produces miRNAs that are bound
by Ago1, and Dicer2 (Dcr2) generates
siRNA, which associates with Ago2. Us-
ing genetic in vivo approaches combined
with immunofluorescence staining of
Ago1, Smibert et al. (2013) show that
genetic inactivation of miRNA processing
factors such as Dcr1 leads to reduced
Ago1 protein levels (Figure 1). This is not
due to transcriptional regulation but
rather to protein degradation because
inhibition of the ubiquitin-proteasome
system stabilized Ago1 under these con-
ditions. Interestingly, Ago2, the siRNA
effector protein, is not controlled by the
levels of siRNAs inDrosophila, suggesting
that the two small RNA pathways employ
different mechanisms to control Ago pro-
tein levels. Smibert et al. (2013) also
analyzed human Ago protein expression.
They find that Ago2 levels are reduced
in Dicer-deficient (and therefore also
miRNA-lacking) mouse embryonic fibro-
blasts. They show that this effect is also
caused by proteasome-mediated protein
degradation and can be rescued by the
transfection of small RNAs. In RNA
interference experiments, it is generally
observed that siRNAs are efficiently
loaded onto Ago2, suggesting the exis-
tence of a pool of free Ago2 that can effi-
ciently take up the transfected small
RNAs. However, the work by Smibert
et al. (2013) now demonstrates that suchDevelopmental Cellstable small RNA-free human Ago2 pools
might not exist and that extra siRNAs
might either compete with endogenous
miRNAs for loading or stimulate Ago2
synthesis by unknown mechanisms.
Whereas Smibert et al. (2013) focused
on homeostatic regulation of Ago, the
work of Shen et al. (2013) examined
the regulation of Ago loading under
hypoxic conditions and uncovers amech-
anism for its regulation by phosphoryla-
tion (Figure 1). Using biochemical ap-
proaches, Shen et al. (2013) find that
Ago2 interacts with the epidermal growth
factor receptor (EGFR) in cultured human
cells. Under hypoxic conditions, often
found in the center of solid tumors,
EGFR is a well-characterized oncogene.
Because miRNAs are also often involved
in cancer, the interaction of EGFR with
Ago2 prompted the authors to analyze
miRNA expression upon EGFR knock-
down under normoxic or hypoxic condi-
tions. Indeed, they find that the expres-
sion of a specific number of miRNAs
depends on EGFR under hypoxic condi-
tions. Based on the current literature,
most of these miRNAs seem to have tu-
mor-suppressive functions. Furthermore,
the EGFR effect on miRNA expression re-
quires a functional kinase domain. Conse-
quently, Shen et al. (2013) find that Ago2
is phosphorylated at tyrosine 393 (Y393)
and that this phosphorylation is mediated
by EGFR. Interestingly, phosphorylation
of Ago2 at Y393 impairs Dicer interaction,
and thus the loading of a specific sub-
class of miRNAs onto Ago2 under hypoxic
conditions (Figure 1). Why is only a limited
number of miRNAs affected by interfering
with the Ago2-Dicer interaction? Shen
et al. (2013) analyzed the precursor25, June 24, 2013 ª2013 Elsevier Inc. 553
Figure 1. Regulation of Ago Proteins by miRNA Availability or Tyrosine Phosphorylation
Ago protein levels are regulated by miRNA availability (left), whereas Ago loading with a specific subset of
miRNAs is controlled by tyrosine phosphorylation (right). In Drosophila and mammals, reduction in miRNA
levels results in Ago protein reduction by ubiquitination-mediated degradation by the proteasome (left).
Under hypoxia conditions, EGFR phosphorylates Ago2 on Y393. A subset of specific, large loop-contain-
ing miRNA precursors is not processed under these conditions. During the RISC loading process, a phos-
phorylated Y393 on Ago2might interfere with the transfer of the processedmiRNA to Ago2, and thus these
miRNAs are not loaded (right).
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found that these miRNAs contain larger
loop structures. The authors therefore
suggest that phosphorylation of Y393
specifically influences the maturation of
these large loop-containing miRNA pre-
cursors in a Dicer-dependent manner.
Using a polyclonal antibody directed spe-
cifically against Y393 phosphorylated
Ago2, the authors analyzed Ago phos-
phorylation status in breast cancer patient
samples. With this approach, they were
able to correlate Y393 Ago2 phosphoryla-
tion with poor patient survival, leading to
a model in which hypoxia-induced upre-
gulation of EGFR results in Ago2 phos-
phorylation and downregulation of several
tumor suppressor miRNAs due to
impaired Ago2 loading.554 Developmental Cell 25, June 24, 2013 ª2Ago proteins are key factors in the
miRNA pathway, and therefore it is not
surprising that these proteins are highly
regulated. When cells react to specific
stimuli or changing conditions, signaling
cascades help to establish new gene
expression programs. miRNAs are impor-
tant pieces in such gene expression net-
works, and their regulation can be
achieved through the phosphorylation
of Drosha (Tang et al., 2010), TRBP
(Paroo et al., 2009), or Ago proteins
(Horman et al., 2013; Ru¨del et al., 2011;
Zeng et al., 2008) proteins. Several addi-
tional phosphorylation sites have been
mapped in different human Ago proteins
(Ru¨del et al., 2011). It is tempting to spec-
ulate that a number of signaling pathways,
in addition to EGFR, also influence Ago013 Elsevier Inc.function. It is also not clear yet whether
different Ago proteins are differentially
phosphorylated and which kinases are
required for these modifications. In
addition, it has been shown that other
posttranslational modifications such as
hydroxylation can affect Ago protein
stability (Qi et al., 2008), suggesting that
Ago protein levels are regulated not only
by miRNA availability but also by a range
of posttranslational modifications. Future
work will unravel the impact of posttrans-
lational modifications on the miRNA
pathway, as well as its consequences for
diseases such as cancer.
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